These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6233382)

  • 1. [Immune functions of patients with systemic lupus erythematosus: abnormalities of immune regulatory circuits activated by autologous mixed lymphocyte reactions and their correction by addition of interleukin 2].
    Sakane T; Takada S; Ueda Y; Murakawa Y; Horwitz DA; Green I; Steinberg AD
    Nihon Naika Gakkai Zasshi; 1983 Dec; 72(12):1697-703. PubMed ID: 6233382
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
    Smolen JS; Siminovitch K; Luger TA; Steinberg AD
    Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
    Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
    J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells.
    Stohl W; Crow MK; Kunkel HG
    N Engl J Med; 1985 Jun; 312(26):1671-8. PubMed ID: 2582253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2.
    Takada S; Ueda Y; Suzuki N; Murakawa Y; Hoshino T; Green I; Steinberg AD; Horwitz DA; Sakane T
    Eur J Immunol; 1985 Mar; 15(3):262-7. PubMed ID: 3156746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.
    Kotani H; Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    Clin Exp Immunol; 1984 May; 56(2):390-8. PubMed ID: 6234113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus.
    Horwitz DA; Linker-Israeli M; Gray JD; Lemoine C
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():49-52. PubMed ID: 2956420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [B lymphocyte-dependent or independent suppressor T cell abnormalities in systemic lupus erythematosus].
    Sakane T; Kotani H; Takada S; Tsunematsu T
    Nihon Naika Gakkai Zasshi; 1982 Sep; 71(9):1237-44. PubMed ID: 6218211
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pan T, T4 and T8-positive lymphocytes in the peripheral blood of patients with systemic lupus erythematosus].
    Grunow R; Volk HD; von Baehr R
    Z Gesamte Inn Med; 1987 Mar; 42(5):130-4. PubMed ID: 2954308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocyte subsets and antilymphocyte antibodies in lupus nephritis.
    Patel R; Patel DR; Najera D
    Clin Nephrol; 1986 Aug; 26(2):83-6. PubMed ID: 2944680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Null cell immunoregulation in SLE.
    Stephens HA; Fitzharris P; Knight RA; Snaith ML
    J Clin Lab Immunol; 1985 Oct; 18(2):55-61. PubMed ID: 2934551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of immune abnormalities in systemic lupus erythematosus.
    Steinberg AD; Smith HR; Laskin CA; Steinberg BJ; Smolen JS
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):101-10. PubMed ID: 6213146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective expression of the 2H4 molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients.
    Takeuchi T; Tanaka S; Steinberg AD; Matsuyama T; Daley J; Schlossman SF; Morimoto C
    J Clin Invest; 1988 Oct; 82(4):1288-94. PubMed ID: 2971675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor T cell activity in rheumatoid arthritis and systemic lupus erythematosus.
    Sakane T; Taniguchi Y; Honda M; Kotani H
    Ryumachi; 1981; 21 Suppl():115-22. PubMed ID: 6211784
    [No Abstract]   [Full Text] [Related]  

  • 16. T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus.
    Frazer IH; Mackay IR
    Clin Exp Immunol; 1982 Oct; 50(1):107-14. PubMed ID: 6216997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells.
    Mach PS; Brouilhet H; Amor B
    Clin Exp Immunol; 1986 Feb; 63(2):408-13. PubMed ID: 2938856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE.
    Surányi P; Mátyus L; Sonkoly I; Szegedi G
    Clin Exp Immunol; 1984 Oct; 58(1):37-41. PubMed ID: 6236918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets in patients with systemic lupus erythematosus.
    Kucharz EJ; Sierakowski SJ
    Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.